Furthermore, high expression of MIC-A/B has been found to be a positive prognostic factor in patients undergoing surgery for NSCLC, and a higher expression of MIC-A specifically has been associated with significantly longer survival times in NSCLC [37,38]. The gene discussed is MICA; the disease is non-small cell lung carcinoma.